We will answer you via email as soon as possible
If they prescribe it, they choose the correct starting dose for you
Medication in injectable form
You know what it's going to continue
Retatrutides rates run a bit hotter than tirzepatide at the top doses, roughly 6 to 16 percent stopping versus 4 to 10 percent, but its the same kinds of effects, not new ones
Serial investor Michael Carter, who has founded and run various gaming and software startups, recently started a company called Finnrick, which he says is "creating the market force for these vendors to care about safety." He said most of the retatrutide samples he has tested are the real deal, the "exact same thing" that Eli Lilly is making, but there's really no way to be totally sure